Clincosm LogoSign in Get a demo

High-grade Serous Ovarian Cancer

Showing 1 - 6 of 6
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Breast Cancer BRCA1 Carriers: a Pilot Study

Withdrawn
  • BRCA1 Mutation
  • +2 more
  • Mifepristone 200 MG
  • Prophylactic mastectomy
  • Carmel, Indiana
  • +1 more
Dec 13, 2022

Platinum-resistant Ovarian Cancer, Platinum-refractory Ovarian Cancer, Fallopian Tube Cancer Trial in Orlando, Albuquerque

Recruiting
  • Platinum-resistant Ovarian Cancer
  • +6 more
  • olvimulogene nanivacirepvec
  • +3 more
  • Orlando, Florida
    AdventHealth Cancer Institute
Sep 1, 2022

High-grade Serous Ovarian Cancer Trial in Belgium, Spain, United Kingdom (APR-246, Pegylated Liposomal Doxorubicin Hydrochloride

Completed
Has Results
  • High-grade Serous Ovarian Cancer
  • APR-246
  • Pegylated Liposomal Doxorubicin Hydrochloride (PLD)
  • Gent, Belgium
  • +11 more
Jul 19, 2022

Pembrolizumab and Anlotinib in Treatment of High-Grade Serous

Completed
  • High-Grade Serous Ovarian Cancer
  • Pembrolizumab combined Anlotinib
  • Qingdao, Shandong, China
    Xiaochun Zhang
Dec 26, 2021

Treatment Efficacy in Patients With Ovarian Cancer

Not yet recruiting
  • High-grade Serous Ovarian Cancer
  • Circulating Tumor DNA
    • (no location specified)
    Aug 25, 2021

    Triple-Negative Breast Cancer, High-grade Serous Ovarian Cancer, Solid Tumors Trial in United States (CUDC-907)

    Completed
    • Triple-Negative Breast Cancer
    • +3 more
    • San Francisco, California
    • +3 more
    Aug 30, 2019